"The nationally accredited Delbert Day Cancer Institute (DDCI) at Phelps Health provides all cancer care services under one roof for convenience and continuity of care for patients and their families."

During the past decade, Delbert Day Cancer Institute at PCRMC conducted 186 clinical trials. In the 10-year time frame, 186 clinical trials started and 84 clinical trials were completed, i.e. on average, 45.2% percent of trials that started reached the finish line to date. In the past 5 years, 84 clinical trials started and 68 clinical trials were completed. i.e. 81% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Delbert Day Cancer Institute at PCRMC" #1 sponsor was "National Cancer Institute (NCI)" with 117 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored and "NRG Oncology" with 19 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delbert Day Cancer Institute at PCRMC" #1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Delbert Day Cancer Institute at PCRMC" are "Invasive Breast Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "Delbert Day Cancer Institute at PCRMC" in a lesser frequency.

Most popular intervention types in "Delbert Day Cancer Institute at PCRMC" are "Drug" (189 trials), "Other" (153 trials), "Biological" (99 trials), "Procedure" (68 trials) and "Radiation" (47 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (77 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (40 trials), "Biospecimen Collection" (35 trials) and "Cisplatin" (33 trials). Other intervention names were less common.

The vast majority of trials in "Delbert Day Cancer Institute at PCRMC" are 189 trials for "All" genders, 41 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Delbert Day Cancer Institute at PCRMC". undefined are not yet recruiting, 80 are recruiting, 108 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Delbert Day Cancer Institute at PCRMC, 9 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Delbert Day Cancer Institute at PCRMC, 7 "Phase 1" clinical trials were conducted, 126 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".